These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 13714488)

  • 41. [THE ROLE OF THE PROPERDIN SYSTEM IN NON-SPECIFIC IMMUNITY].
    HOSHINO A
    Nihon Naika Gakkai Zasshi; 1963 Dec; 52():1023-40. PubMed ID: 14158037
    [No Abstract]   [Full Text] [Related]  

  • 42. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
    Brade V; Lee GD; Nicholson A; Shin HS; Mayer MM
    J Immunol; 1973 Nov; 111(5):1389-400. PubMed ID: 4795621
    [No Abstract]   [Full Text] [Related]  

  • 43. Isolation and characterization of Guinea pig properidin.
    Nicholson A; Austen KF
    J Immunol; 1977 Jan; 118(1):103-8. PubMed ID: 830742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [INFLUENCE OF ZYMOSAN ON THE GRANULOPEXIC ACTIVITY OF THE RETICULO-HISTIOCYTIC SYSTEM STUDIED WITH AU-198].
    DIOMEDE-FRESA V; FUMAROLA D; DERINALDIS P
    Minerva Nucl; 1964; 8():34-6. PubMed ID: 14154012
    [No Abstract]   [Full Text] [Related]  

  • 45. [PROPERDIN AND ANAPHYLATOXIN].
    WILLEMS G
    Rev Immunol Ther Antimicrob; 1963; 27():285-90. PubMed ID: 14111198
    [No Abstract]   [Full Text] [Related]  

  • 46. THE CLINICO-PATHOLOGICAL SIGNIFICANCE OF THE VARIABILITY OF THE SERUM-PROPERDIN-LEVEL IN TUMORS.
    NAGY IS; KOSZORU M; MAJOROSSY K; VAJDA J
    Acta Unio Int Contra Cancrum; 1964; 20():1241-3. PubMed ID: 14274746
    [No Abstract]   [Full Text] [Related]  

  • 47. Properdin system and immunity. II. Interaction of the properdin system with polysaccharides.
    PILLEMER L; SCHOENBERG MD; BLUM L; WURZ L
    Science; 1955 Sep; 122(3169):545-9. PubMed ID: 13255887
    [No Abstract]   [Full Text] [Related]  

  • 48. Functional relationship of factor B in the properdin system to C3 proactivator of human serum.
    Goodkofsky I; Lepow IH
    J Immunol; 1971 Oct; 107(4):1200-4. PubMed ID: 5093780
    [No Abstract]   [Full Text] [Related]  

  • 49. Quantitative studies of the properdin-complement system. III. Kinetics of the reaction between C'3 and the properdin-zymosan complex.
    LEON MA
    J Immunol; 1958 Jul; 81(1):23-8. PubMed ID: 13563875
    [No Abstract]   [Full Text] [Related]  

  • 50. [Validity and limitations in the determination of serum properdin by means of zymosan].
    ZANUSSI C; TASCHINI P; SELVA G; ORTOLANI C
    Boll Ist Sieroter Milan; 1958; 37(5-6):237-45. PubMed ID: 13560652
    [No Abstract]   [Full Text] [Related]  

  • 51. [Bactericidal activity of normal and low-properdin sera and of properdin-zymosan complexes].
    SZEMERE G
    Kiserl Orvostud; 1963 Feb; 15():58-61. PubMed ID: 13979914
    [No Abstract]   [Full Text] [Related]  

  • 52. Increased resistance to infection and accompanying alteration in properidin levels following administration of bacterial lipopolysaccharides.
    LANDY M; PILLEMER L
    J Exp Med; 1956 Sep; 104(3):383-409. PubMed ID: 13357692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Properdin research. 1. Review of the properdin system and its problems; determination possibilities, assay of sera with high titer levels].
    Zimmermann G
    Arch Exp Veterinarmed; 1972; 26(2):221-46. PubMed ID: 4562974
    [No Abstract]   [Full Text] [Related]  

  • 54. The enhancement of hemolysin production in the rat by Zymosan.
    CUTLER JL
    J Immunol; 1960 Apr; 84():416-9. PubMed ID: 13813447
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies on the mechanism of properdin--zymosan reaction. The role of polysaccharide structure in combination with properdin.
    CSEH G; SZABO I
    Acta Microbiol Acad Sci Hung; 1961; 8():181-7. PubMed ID: 13718704
    [No Abstract]   [Full Text] [Related]  

  • 56. [Experimental studies on the properdin system of the rabbit. (IV) Relationship of properdin titer and antibody-forming activity].
    YAMAMASU N
    Nihon Saikingaku Zasshi; 1961 Dec; 16():1084-9. PubMed ID: 14008820
    [No Abstract]   [Full Text] [Related]  

  • 57. Changes in the immunochemical properties of highly purified properdin in human serum.
    Minta JO
    J Immunol; 1975 Apr; 114(4):1415-21. PubMed ID: 123262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SOME RES EFFECTS INFLUENCING RADIATION SURVIVAL TIME.
    SZANTO A
    Acta Unio Int Contra Cancrum; 1964; 20():1233-5. PubMed ID: 14274743
    [No Abstract]   [Full Text] [Related]  

  • 59. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
    Brade V; Nicholson A; Lee GD; Mayer MM
    J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
    [No Abstract]   [Full Text] [Related]  

  • 60. Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly.
    Nicholson A; Brade V; Lee GD; Shin HS; Mayer MM
    J Immunol; 1974 Mar; 112(3):1115-23. PubMed ID: 4811964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.